Unique ID issued by UMIN | UMIN000058140 |
---|---|
Receipt number | R000066453 |
Scientific Title | Effects of Seabuckthorn Juice Consumption on Anti-Fatigue and Q0L in male |
Date of disclosure of the study information | 2025/06/12 |
Last modified on | 2025/06/10 14:19:27 |
Effects of Seabuckthorn Juice Consumption on Anti-Fatigue and Q0L in male
Effects of Seabuckthorn Juice Consumption on Anti-Fatigue and Q0L in male
Effects of Seabuckthorn Juice Consumption on Anti-Fatigue and Q0L in male
Effects of Seabuckthorn Juice Consumption on Anti-Fatigue and Q0L in male
Japan |
Healthy male
Adult |
Others
NO
Check anti-fatigue and quality of life with Seabuckthorn drink intake in male
Safety,Efficacy
QOL Questionnaire for Daily Life
Blood test related to anemia, temporary fatigue when performing work tasks
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
No need to know
2
Treatment
Food |
Intake of Seabuckthorn juice
Intake of placebo juice
20 | years-old | <= |
50 | years-old | > |
Male
(1) Those who are temporarily fatigued or have low vitality due to a desk-bound job
(2) male between the ages of 20 and 50
(3) BMI less than 30 kg/m2
(4) Persons who give written voluntary consent to participate in the study
(5) Those who can continue to drink Seabuckthorn
(1) Those who are currently under medication for iron deficiency anemia
(2) Those who are currently receiving medication for some disease.
(3) Those who are consuming food products containing the ingredients of this test food or health food products.
(4) Persons with serious diseases of glucose metabolism, lipid metabolism, liver function, renal function, heart, circulatory system, respiratory system, endocrine system, immune system, nervous system or psychiatric disorders.Persons with a history of such diseases
(5) Persons with a history of abnormal clinical laboratory values that would be considered problematic for study participation
(6) Persons who have a disease under treatment or a history of a serious disease that required medication
(7) Persons who may develop allergies related to the study
(8) Persons who are judged to be unsuitable as subjects based on the results of the lifestyle questionnaire
(9) Subjects who are participating in other clinical studies at the time this study is initiated.
(10) Persons who are judged to be unsuitable to participate in the study by the investigator (or study administrator).
20
1st name | Ryuji |
Middle name | |
Last name | Takeda |
Kansai University of Welfare Sciences
Department of Nutritional Sciences for Welll-being Faculty of Health Science for Welfare
582-0026
Asahigaoka 3-11-, Kashiwara-city, Osaka, Japan
072-978-0088
rtakeda@tamateyama.ac.jp
1st name | Shigefumi |
Middle name | |
Last name | Nibun |
EAS inc.
Clinical Trial Session
239-0028
Susaki-Cho1-10-2F, Kanazawa-ku, Yokohama city, Kanagawa
045-374-3392
info@eas-ct.jp
Finess Co, Ltd.
Finess Co, Ltd.
Profit organization
Japan
KOBUNA ORTHOPEDIC SURGERY
311-2, Gokan-machi, Maebashi, Gunma
027-261-7600
info@kobunaseikei.jp
NO
2025 | Year | 06 | Month | 12 | Day |
Unpublished
Preinitiation
2025 | Year | 05 | Month | 14 | Day |
2025 | Year | 05 | Month | 22 | Day |
2025 | Year | 06 | Month | 13 | Day |
2025 | Year | 08 | Month | 31 | Day |
2025 | Year | 06 | Month | 10 | Day |
2025 | Year | 06 | Month | 10 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066453